nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclophosphamide—CYP2A6—Arformoterol—chronic obstructive pulmonary disease	0.0978	0.131	CbGbCtD
Cyclophosphamide—CYP2A6—Formoterol—chronic obstructive pulmonary disease	0.0978	0.131	CbGbCtD
Cyclophosphamide—CYP2A6—Montelukast—chronic obstructive pulmonary disease	0.0741	0.0989	CbGbCtD
Cyclophosphamide—CYP2A6—Prednisolone—chronic obstructive pulmonary disease	0.0435	0.058	CbGbCtD
Cyclophosphamide—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.0404	0.054	CbGbCtD
Cyclophosphamide—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.0404	0.054	CbGbCtD
Cyclophosphamide—CYP2C8—Montelukast—chronic obstructive pulmonary disease	0.0365	0.0488	CbGbCtD
Cyclophosphamide—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.0336	0.0449	CbGbCtD
Cyclophosphamide—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.0336	0.0449	CbGbCtD
Cyclophosphamide—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0307	0.041	CbGbCtD
Cyclophosphamide—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0307	0.041	CbGbCtD
Cyclophosphamide—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0274	0.0366	CbGbCtD
Cyclophosphamide—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0258	0.0344	CbGbCtD
Cyclophosphamide—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.0255	0.034	CbGbCtD
Cyclophosphamide—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0174	0.0233	CbGbCtD
Cyclophosphamide—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.017	0.0227	CbGbCtD
Cyclophosphamide—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0166	0.0222	CbGbCtD
Cyclophosphamide—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0148	0.0198	CbGbCtD
Cyclophosphamide—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.0145	0.0194	CbGbCtD
Cyclophosphamide—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.0137	0.0183	CbGbCtD
Cyclophosphamide—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0087	0.0116	CbGbCtD
Cyclophosphamide—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00821	0.011	CbGbCtD
Cyclophosphamide—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.000299	0.00171	CcSEcCtD
Cyclophosphamide—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.000297	0.0017	CcSEcCtD
Cyclophosphamide—Ill-defined disorder—Formoterol—chronic obstructive pulmonary disease	0.000296	0.0017	CcSEcCtD
Cyclophosphamide—Ill-defined disorder—Arformoterol—chronic obstructive pulmonary disease	0.000296	0.0017	CcSEcCtD
Cyclophosphamide—Dysgeusia—Salbutamol—chronic obstructive pulmonary disease	0.000295	0.00169	CcSEcCtD
Cyclophosphamide—Vasculitis—Prednisone—chronic obstructive pulmonary disease	0.000294	0.00169	CcSEcCtD
Cyclophosphamide—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.000294	0.00168	CcSEcCtD
Cyclophosphamide—Agitation—Formoterol—chronic obstructive pulmonary disease	0.000293	0.00168	CcSEcCtD
Cyclophosphamide—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.000293	0.00168	CcSEcCtD
Cyclophosphamide—Tremor—Montelukast—chronic obstructive pulmonary disease	0.000292	0.00168	CcSEcCtD
Cyclophosphamide—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.000289	0.00166	CcSEcCtD
Cyclophosphamide—Muscle spasms—Salbutamol—chronic obstructive pulmonary disease	0.000289	0.00166	CcSEcCtD
Cyclophosphamide—Malaise—Formoterol—chronic obstructive pulmonary disease	0.000287	0.00165	CcSEcCtD
Cyclophosphamide—Malaise—Arformoterol—chronic obstructive pulmonary disease	0.000287	0.00165	CcSEcCtD
Cyclophosphamide—Agitation—Montelukast—chronic obstructive pulmonary disease	0.000287	0.00164	CcSEcCtD
Cyclophosphamide—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.000282	0.00162	CcSEcCtD
Cyclophosphamide—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.000282	0.00161	CcSEcCtD
Cyclophosphamide—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.000282	0.00161	CcSEcCtD
Cyclophosphamide—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.000279	0.0016	CcSEcCtD
Cyclophosphamide—Cough—Formoterol—chronic obstructive pulmonary disease	0.000278	0.00159	CcSEcCtD
Cyclophosphamide—Cough—Arformoterol—chronic obstructive pulmonary disease	0.000278	0.00159	CcSEcCtD
Cyclophosphamide—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.000277	0.00159	CcSEcCtD
Cyclophosphamide—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.000276	0.00158	CcSEcCtD
Cyclophosphamide—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000276	0.00158	CcSEcCtD
Cyclophosphamide—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.000275	0.00158	CcSEcCtD
Cyclophosphamide—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.000275	0.00158	CcSEcCtD
Cyclophosphamide—Cardiac arrest—Prednisolone—chronic obstructive pulmonary disease	0.000273	0.00156	CcSEcCtD
Cyclophosphamide—Cough—Montelukast—chronic obstructive pulmonary disease	0.000272	0.00156	CcSEcCtD
Cyclophosphamide—Fluid retention—Prednisone—chronic obstructive pulmonary disease	0.000272	0.00156	CcSEcCtD
Cyclophosphamide—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000271	0.00156	CcSEcCtD
Cyclophosphamide—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.000271	0.00156	CcSEcCtD
Cyclophosphamide—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000271	0.00156	CcSEcCtD
Cyclophosphamide—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.000271	0.00156	CcSEcCtD
Cyclophosphamide—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.000271	0.00156	CcSEcCtD
Cyclophosphamide—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000271	0.00156	CcSEcCtD
Cyclophosphamide—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000271	0.00156	CcSEcCtD
Cyclophosphamide—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000271	0.00156	CcSEcCtD
Cyclophosphamide—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.00027	0.00155	CcSEcCtD
Cyclophosphamide—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.00027	0.00155	CcSEcCtD
Cyclophosphamide—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000268	0.00154	CcSEcCtD
Cyclophosphamide—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000268	0.00154	CcSEcCtD
Cyclophosphamide—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000266	0.00152	CcSEcCtD
Cyclophosphamide—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000266	0.00152	CcSEcCtD
Cyclophosphamide—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000266	0.00152	CcSEcCtD
Cyclophosphamide—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000263	0.00151	CcSEcCtD
Cyclophosphamide—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.00026	0.00149	CcSEcCtD
Cyclophosphamide—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.00026	0.00149	CcSEcCtD
Cyclophosphamide—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.00026	0.00149	CcSEcCtD
Cyclophosphamide—Oedema—Formoterol—chronic obstructive pulmonary disease	0.00026	0.00149	CcSEcCtD
Cyclophosphamide—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.00026	0.00149	CcSEcCtD
Cyclophosphamide—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000258	0.00148	CcSEcCtD
Cyclophosphamide—Infection—Formoterol—chronic obstructive pulmonary disease	0.000258	0.00148	CcSEcCtD
Cyclophosphamide—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000256	0.00147	CcSEcCtD
Cyclophosphamide—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000256	0.00147	CcSEcCtD
Cyclophosphamide—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000256	0.00147	CcSEcCtD
Cyclophosphamide—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000256	0.00147	CcSEcCtD
Cyclophosphamide—Pulmonary oedema—Prednisone—chronic obstructive pulmonary disease	0.000255	0.00146	CcSEcCtD
Cyclophosphamide—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000255	0.00146	CcSEcCtD
Cyclophosphamide—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000255	0.00146	CcSEcCtD
Cyclophosphamide—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000254	0.00146	CcSEcCtD
Cyclophosphamide—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000254	0.00146	CcSEcCtD
Cyclophosphamide—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000253	0.00145	CcSEcCtD
Cyclophosphamide—Infection—Montelukast—chronic obstructive pulmonary disease	0.000253	0.00145	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000252	0.00144	CcSEcCtD
Cyclophosphamide—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000249	0.00143	CcSEcCtD
Cyclophosphamide—Sepsis—Prednisone—chronic obstructive pulmonary disease	0.000249	0.00143	CcSEcCtD
Cyclophosphamide—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000246	0.00141	CcSEcCtD
Cyclophosphamide—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000246	0.00141	CcSEcCtD
Cyclophosphamide—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000244	0.0014	CcSEcCtD
Cyclophosphamide—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000243	0.00139	CcSEcCtD
Cyclophosphamide—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000243	0.00139	CcSEcCtD
Cyclophosphamide—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000242	0.00139	CcSEcCtD
Cyclophosphamide—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000242	0.00139	CcSEcCtD
Cyclophosphamide—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.000241	0.00138	CcSEcCtD
Cyclophosphamide—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.00024	0.00137	CcSEcCtD
Cyclophosphamide—Diabetes mellitus—Prednisone—chronic obstructive pulmonary disease	0.000239	0.00137	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000237	0.00136	CcSEcCtD
Cyclophosphamide—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000237	0.00136	CcSEcCtD
Cyclophosphamide—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000237	0.00136	CcSEcCtD
Cyclophosphamide—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000237	0.00136	CcSEcCtD
Cyclophosphamide—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000234	0.00134	CcSEcCtD
Cyclophosphamide—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000234	0.00134	CcSEcCtD
Cyclophosphamide—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000232	0.00133	CcSEcCtD
Cyclophosphamide—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000232	0.00133	CcSEcCtD
Cyclophosphamide—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000232	0.00133	CcSEcCtD
Cyclophosphamide—Cardiac failure congestive—Prednisone—chronic obstructive pulmonary disease	0.00023	0.00132	CcSEcCtD
Cyclophosphamide—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000229	0.00132	CcSEcCtD
Cyclophosphamide—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000229	0.00131	CcSEcCtD
Cyclophosphamide—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000228	0.00131	CcSEcCtD
Cyclophosphamide—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000226	0.0013	CcSEcCtD
Cyclophosphamide—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000225	0.00129	CcSEcCtD
Cyclophosphamide—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000224	0.00129	CcSEcCtD
Cyclophosphamide—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000224	0.00129	CcSEcCtD
Cyclophosphamide—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000224	0.00128	CcSEcCtD
Cyclophosphamide—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000222	0.00128	CcSEcCtD
Cyclophosphamide—Pain—Formoterol—chronic obstructive pulmonary disease	0.000222	0.00128	CcSEcCtD
Cyclophosphamide—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000222	0.00128	CcSEcCtD
Cyclophosphamide—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000222	0.00128	CcSEcCtD
Cyclophosphamide—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000221	0.00126	CcSEcCtD
Cyclophosphamide—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.00022	0.00126	CcSEcCtD
Cyclophosphamide—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000219	0.00126	CcSEcCtD
Cyclophosphamide—Pain—Montelukast—chronic obstructive pulmonary disease	0.000218	0.00125	CcSEcCtD
Cyclophosphamide—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000218	0.00125	CcSEcCtD
Cyclophosphamide—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000217	0.00125	CcSEcCtD
Cyclophosphamide—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000216	0.00124	CcSEcCtD
Cyclophosphamide—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.000216	0.00124	CcSEcCtD
Cyclophosphamide—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000215	0.00124	CcSEcCtD
Cyclophosphamide—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000215	0.00123	CcSEcCtD
Cyclophosphamide—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000215	0.00123	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000214	0.00123	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000214	0.00123	CcSEcCtD
Cyclophosphamide—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000214	0.00123	CcSEcCtD
Cyclophosphamide—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000213	0.00122	CcSEcCtD
Cyclophosphamide—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	0.000213	0.00122	CcSEcCtD
Cyclophosphamide—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000213	0.00122	CcSEcCtD
Cyclophosphamide—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000212	0.00121	CcSEcCtD
Cyclophosphamide—Pain—Salbutamol—chronic obstructive pulmonary disease	0.00021	0.0012	CcSEcCtD
Cyclophosphamide—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.00021	0.0012	CcSEcCtD
Cyclophosphamide—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000208	0.00119	CcSEcCtD
Cyclophosphamide—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000207	0.00118	CcSEcCtD
Cyclophosphamide—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000207	0.00118	CcSEcCtD
Cyclophosphamide—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000206	0.00118	CcSEcCtD
Cyclophosphamide—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000206	0.00118	CcSEcCtD
Cyclophosphamide—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000205	0.00117	CcSEcCtD
Cyclophosphamide—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000203	0.00116	CcSEcCtD
Cyclophosphamide—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000203	0.00116	CcSEcCtD
Cyclophosphamide—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000203	0.00116	CcSEcCtD
Cyclophosphamide—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000202	0.00116	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000202	0.00116	CcSEcCtD
Cyclophosphamide—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000202	0.00116	CcSEcCtD
Cyclophosphamide—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000202	0.00116	CcSEcCtD
Cyclophosphamide—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000201	0.00115	CcSEcCtD
Cyclophosphamide—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.000199	0.00114	CcSEcCtD
Cyclophosphamide—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.000198	0.00114	CcSEcCtD
Cyclophosphamide—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	0.000198	0.00114	CcSEcCtD
Cyclophosphamide—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000195	0.00112	CcSEcCtD
Cyclophosphamide—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000194	0.00111	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000192	0.0011	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000192	0.0011	CcSEcCtD
Cyclophosphamide—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000191	0.0011	CcSEcCtD
Cyclophosphamide—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000191	0.0011	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000188	0.00108	CcSEcCtD
Cyclophosphamide—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000187	0.00107	CcSEcCtD
Cyclophosphamide—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000187	0.00107	CcSEcCtD
Cyclophosphamide—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000184	0.00105	CcSEcCtD
Cyclophosphamide—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000184	0.00105	CcSEcCtD
Cyclophosphamide—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000183	0.00105	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000181	0.00104	CcSEcCtD
Cyclophosphamide—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.00018	0.00103	CcSEcCtD
Cyclophosphamide—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000178	0.00102	CcSEcCtD
Cyclophosphamide—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000178	0.00102	CcSEcCtD
Cyclophosphamide—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000177	0.00102	CcSEcCtD
Cyclophosphamide—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000176	0.00101	CcSEcCtD
Cyclophosphamide—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.000175	0.00101	CcSEcCtD
Cyclophosphamide—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000174	0.000999	CcSEcCtD
Cyclophosphamide—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000174	0.000996	CcSEcCtD
Cyclophosphamide—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000173	0.000989	CcSEcCtD
Cyclophosphamide—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000172	0.000986	CcSEcCtD
Cyclophosphamide—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000172	0.000986	CcSEcCtD
Cyclophosphamide—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000168	0.000966	CcSEcCtD
Cyclophosphamide—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000168	0.000963	CcSEcCtD
Cyclophosphamide—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000165	0.000948	CcSEcCtD
Cyclophosphamide—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000165	0.000948	CcSEcCtD
Cyclophosphamide—Rash—Formoterol—chronic obstructive pulmonary disease	0.000164	0.00094	CcSEcCtD
Cyclophosphamide—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000164	0.00094	CcSEcCtD
Cyclophosphamide—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000164	0.000939	CcSEcCtD
Cyclophosphamide—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000164	0.000939	CcSEcCtD
Cyclophosphamide—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.000164	0.000939	CcSEcCtD
Cyclophosphamide—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000163	0.000934	CcSEcCtD
Cyclophosphamide—Headache—Formoterol—chronic obstructive pulmonary disease	0.000163	0.000934	CcSEcCtD
Cyclophosphamide—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000163	0.000933	CcSEcCtD
Cyclophosphamide—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000162	0.000931	CcSEcCtD
Cyclophosphamide—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.000162	0.000931	CcSEcCtD
Cyclophosphamide—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000162	0.000929	CcSEcCtD
Cyclophosphamide—Rash—Montelukast—chronic obstructive pulmonary disease	0.000161	0.000921	CcSEcCtD
Cyclophosphamide—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.00016	0.00092	CcSEcCtD
Cyclophosphamide—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.00016	0.000918	CcSEcCtD
Cyclophosphamide—Headache—Montelukast—chronic obstructive pulmonary disease	0.00016	0.000915	CcSEcCtD
Cyclophosphamide—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.000158	0.000907	CcSEcCtD
Cyclophosphamide—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.000157	0.000902	CcSEcCtD
Cyclophosphamide—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.000157	0.000902	CcSEcCtD
Cyclophosphamide—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000156	0.000895	CcSEcCtD
Cyclophosphamide—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000156	0.000892	CcSEcCtD
Cyclophosphamide—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000155	0.000888	CcSEcCtD
Cyclophosphamide—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000155	0.000887	CcSEcCtD
Cyclophosphamide—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000154	0.000886	CcSEcCtD
Cyclophosphamide—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000154	0.000886	CcSEcCtD
Cyclophosphamide—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000154	0.000882	CcSEcCtD
Cyclophosphamide—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000151	0.000868	CcSEcCtD
Cyclophosphamide—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.00015	0.000857	CcSEcCtD
Cyclophosphamide—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000149	0.000854	CcSEcCtD
Cyclophosphamide—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.000147	0.000841	CcSEcCtD
Cyclophosphamide—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000146	0.000836	CcSEcCtD
Cyclophosphamide—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000145	0.000832	CcSEcCtD
Cyclophosphamide—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.000145	0.00083	CcSEcCtD
Cyclophosphamide—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000144	0.000826	CcSEcCtD
Cyclophosphamide—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000141	0.000808	CcSEcCtD
Cyclophosphamide—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000141	0.000808	CcSEcCtD
Cyclophosphamide—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000139	0.000795	CcSEcCtD
Cyclophosphamide—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000137	0.000788	CcSEcCtD
Cyclophosphamide—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000136	0.000781	CcSEcCtD
Cyclophosphamide—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000134	0.000767	CcSEcCtD
Cyclophosphamide—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.000129	0.000738	CcSEcCtD
Cyclophosphamide—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000127	0.00073	CcSEcCtD
Cyclophosphamide—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000126	0.000725	CcSEcCtD
Cyclophosphamide—Erythema—Prednisone—chronic obstructive pulmonary disease	0.000125	0.000719	CcSEcCtD
Cyclophosphamide—Pain—Prednisolone—chronic obstructive pulmonary disease	0.00012	0.000691	CcSEcCtD
Cyclophosphamide—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000118	0.000678	CcSEcCtD
Cyclophosphamide—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000116	0.000667	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000116	0.000665	CcSEcCtD
Cyclophosphamide—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000116	0.000665	CcSEcCtD
Cyclophosphamide—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000115	0.000661	CcSEcCtD
Cyclophosphamide—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000113	0.000648	CcSEcCtD
Cyclophosphamide—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000112	0.000642	CcSEcCtD
Cyclophosphamide—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000109	0.000623	CcSEcCtD
Cyclophosphamide—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000108	0.000621	CcSEcCtD
Cyclophosphamide—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000107	0.000612	CcSEcCtD
Cyclophosphamide—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000107	0.000612	CcSEcCtD
Cyclophosphamide—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000105	0.000605	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000104	0.000595	CcSEcCtD
Cyclophosphamide—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000102	0.000587	CcSEcCtD
Cyclophosphamide—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000102	0.000587	CcSEcCtD
Cyclophosphamide—Infection—Prednisone—chronic obstructive pulmonary disease	0.000102	0.000583	CcSEcCtD
Cyclophosphamide—Shock—Prednisone—chronic obstructive pulmonary disease	0.000101	0.000577	CcSEcCtD
Cyclophosphamide—Tachycardia—Prednisone—chronic obstructive pulmonary disease	9.99e-05	0.000573	CcSEcCtD
Cyclophosphamide—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	9.9e-05	0.000567	CcSEcCtD
Cyclophosphamide—Anorexia—Prednisone—chronic obstructive pulmonary disease	9.76e-05	0.000559	CcSEcCtD
Cyclophosphamide—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	9.71e-05	0.00127	CbGpPWpGaD
Cyclophosphamide—ABCB1—HIF-1-alpha transcription factor network—NOS2—chronic obstructive pulmonary disease	9.6e-05	0.00126	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	9.36e-05	0.00123	CbGpPWpGaD
Cyclophosphamide—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	9.33e-05	0.000535	CcSEcCtD
Cyclophosphamide—Dizziness—Prednisolone—chronic obstructive pulmonary disease	9.31e-05	0.000534	CcSEcCtD
Cyclophosphamide—CYP2A6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	9.27e-05	0.00121	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Biological oxidations—GCLC—chronic obstructive pulmonary disease	9.26e-05	0.00121	CbGpPWpGaD
Cyclophosphamide—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	9.19e-05	0.000527	CcSEcCtD
Cyclophosphamide—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	8.9e-05	0.00051	CcSEcCtD
Cyclophosphamide—Rash—Prednisolone—chronic obstructive pulmonary disease	8.88e-05	0.000509	CcSEcCtD
Cyclophosphamide—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	8.87e-05	0.000509	CcSEcCtD
Cyclophosphamide—Fatigue—Prednisone—chronic obstructive pulmonary disease	8.82e-05	0.000506	CcSEcCtD
Cyclophosphamide—Headache—Prednisolone—chronic obstructive pulmonary disease	8.82e-05	0.000506	CcSEcCtD
Cyclophosphamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	8.81e-05	0.00115	CbGpPWpGaD
Cyclophosphamide—Constipation—Prednisone—chronic obstructive pulmonary disease	8.75e-05	0.000502	CcSEcCtD
Cyclophosphamide—CYP2C8—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	8.72e-05	0.00114	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	8.61e-05	0.00113	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	8.6e-05	0.00113	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	8.59e-05	0.00112	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	8.54e-05	0.00112	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Biological oxidations—GCLC—chronic obstructive pulmonary disease	8.51e-05	0.00111	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	8.47e-05	0.00111	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Biological oxidations—GCLC—chronic obstructive pulmonary disease	8.44e-05	0.0011	CbGpPWpGaD
Cyclophosphamide—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	8.43e-05	0.000484	CcSEcCtD
Cyclophosphamide—CYP3A5—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	8.4e-05	0.0011	CbGpPWpGaD
Cyclophosphamide—Nausea—Prednisolone—chronic obstructive pulmonary disease	8.37e-05	0.00048	CcSEcCtD
Cyclophosphamide—CYP3A5—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	8.28e-05	0.00108	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—APIP—chronic obstructive pulmonary disease	8.14e-05	0.00107	CbGpPWpGaD
Cyclophosphamide—Urticaria—Prednisone—chronic obstructive pulmonary disease	8.13e-05	0.000466	CcSEcCtD
Cyclophosphamide—CYP2C18—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	8.11e-05	0.00106	CbGpPWpGaD
Cyclophosphamide—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	8.09e-05	0.000464	CcSEcCtD
Cyclophosphamide—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—chronic obstructive pulmonary disease	8.09e-05	0.00106	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	7.9e-05	0.00103	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	7.89e-05	0.00103	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Metabolism—GC—chronic obstructive pulmonary disease	7.89e-05	0.00103	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	7.79e-05	0.00102	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	7.79e-05	0.00102	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	7.78e-05	0.00102	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	7.72e-05	0.00101	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	7.68e-05	0.001	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	7.61e-05	0.000996	CbGpPWpGaD
Cyclophosphamide—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	7.54e-05	0.000432	CcSEcCtD
Cyclophosphamide—CYP2B6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	7.48e-05	0.000979	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—APIP—chronic obstructive pulmonary disease	7.46e-05	0.000977	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	7.38e-05	0.000966	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	7.37e-05	0.000965	CbGpPWpGaD
Cyclophosphamide—Asthenia—Prednisone—chronic obstructive pulmonary disease	7.34e-05	0.000421	CcSEcCtD
Cyclophosphamide—CYP2C18—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	7.34e-05	0.00096	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	7.31e-05	0.000957	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	7.27e-05	0.000952	CbGpPWpGaD
Cyclophosphamide—Pruritus—Prednisone—chronic obstructive pulmonary disease	7.24e-05	0.000415	CcSEcCtD
Cyclophosphamide—CYP3A5—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	7.21e-05	0.000944	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	7.17e-05	0.000939	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	7.16e-05	0.000937	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	7.1e-05	0.000929	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	7.06e-05	0.000924	CbGpPWpGaD
Cyclophosphamide—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	7e-05	0.000402	CcSEcCtD
Cyclophosphamide—CYP2C9—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	7e-05	0.000916	CbGpPWpGaD
Cyclophosphamide—Dizziness—Prednisone—chronic obstructive pulmonary disease	6.77e-05	0.000388	CcSEcCtD
Cyclophosphamide—CYP2C8—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	6.68e-05	0.000875	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	6.59e-05	0.000863	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	6.58e-05	0.000862	CbGpPWpGaD
Cyclophosphamide—Vomiting—Prednisone—chronic obstructive pulmonary disease	6.51e-05	0.000373	CcSEcCtD
Cyclophosphamide—CYP2C19—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	6.49e-05	0.00085	CbGpPWpGaD
Cyclophosphamide—Rash—Prednisone—chronic obstructive pulmonary disease	6.45e-05	0.00037	CcSEcCtD
Cyclophosphamide—Dermatitis—Prednisone—chronic obstructive pulmonary disease	6.45e-05	0.00037	CcSEcCtD
Cyclophosphamide—Headache—Prednisone—chronic obstructive pulmonary disease	6.41e-05	0.000368	CcSEcCtD
Cyclophosphamide—CYP2C19—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	6.4e-05	0.000838	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	6.4e-05	0.000838	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	6.34e-05	0.000829	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	6.25e-05	0.000818	CbGpPWpGaD
Cyclophosphamide—Nausea—Prednisone—chronic obstructive pulmonary disease	6.08e-05	0.000349	CcSEcCtD
Cyclophosphamide—CYP2B6—Metabolism—APIP—chronic obstructive pulmonary disease	6.02e-05	0.000788	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	6e-05	0.000786	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	5.97e-05	0.000781	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	5.96e-05	0.000781	CbGpPWpGaD
Cyclophosphamide—ABCB1—Allograft Rejection—CXCL8—chronic obstructive pulmonary disease	5.93e-05	0.000776	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	5.92e-05	0.000775	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	5.89e-05	0.000771	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—APIP—chronic obstructive pulmonary disease	5.88e-05	0.00077	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	5.88e-05	0.00077	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	5.84e-05	0.000764	CbGpPWpGaD
Cyclophosphamide—ABCB1—Allograft Rejection—IL1B—chronic obstructive pulmonary disease	5.69e-05	0.000745	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	5.65e-05	0.00074	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	5.63e-05	0.000737	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	5.58e-05	0.00073	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	5.57e-05	0.000729	CbGpPWpGaD
Cyclophosphamide—ABCB1—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	5.56e-05	0.000728	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	5.49e-05	0.000718	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	5.44e-05	0.000712	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	5.41e-05	0.000708	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	5.39e-05	0.000706	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	5.36e-05	0.000702	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—GC—chronic obstructive pulmonary disease	5.25e-05	0.000687	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	5.2e-05	0.000681	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	5.16e-05	0.000675	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	5.13e-05	0.000671	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—APIP—chronic obstructive pulmonary disease	5.1e-05	0.000667	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	5.09e-05	0.000666	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.94e-05	0.000647	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.88e-05	0.000638	CbGpPWpGaD
Cyclophosphamide—ABCB1—Allograft Rejection—VEGFA—chronic obstructive pulmonary disease	4.82e-05	0.000631	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—GC—chronic obstructive pulmonary disease	4.81e-05	0.000629	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	4.68e-05	0.000613	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	4.62e-05	0.000604	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—APIP—chronic obstructive pulmonary disease	4.55e-05	0.000595	CbGpPWpGaD
Cyclophosphamide—CYP2A6—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	4.55e-05	0.000595	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.47e-05	0.000585	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—APIP—chronic obstructive pulmonary disease	4.44e-05	0.000581	CbGpPWpGaD
Cyclophosphamide—ABCB1—Allograft Rejection—TGFB1—chronic obstructive pulmonary disease	4.42e-05	0.000579	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.31e-05	0.000564	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Metabolism—GCLC—chronic obstructive pulmonary disease	4.26e-05	0.000558	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—APIP—chronic obstructive pulmonary disease	4.18e-05	0.000548	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	4.15e-05	0.000543	CbGpPWpGaD
Cyclophosphamide—ABCB1—Allograft Rejection—TNF—chronic obstructive pulmonary disease	4.13e-05	0.00054	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.99e-05	0.000522	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.9e-05	0.000511	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.9e-05	0.00051	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Metabolism—CTGF—chronic obstructive pulmonary disease	3.89e-05	0.000509	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—GC—chronic obstructive pulmonary disease	3.88e-05	0.000508	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.85e-05	0.000504	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—GC—chronic obstructive pulmonary disease	3.79e-05	0.000496	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	3.63e-05	0.000476	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.61e-05	0.000472	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.59e-05	0.000469	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.58e-05	0.000469	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.54e-05	0.000463	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.53e-05	0.000461	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.4e-05	0.000445	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.38e-05	0.000442	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.35e-05	0.000439	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	3.35e-05	0.000438	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—GC—chronic obstructive pulmonary disease	3.28e-05	0.00043	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	3.24e-05	0.000425	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.05e-05	0.0004	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.01e-05	0.000394	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.99e-05	0.000391	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.99e-05	0.000391	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.96e-05	0.000387	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.95e-05	0.000386	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.94e-05	0.000385	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—GC—chronic obstructive pulmonary disease	2.93e-05	0.000384	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.87e-05	0.000375	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	2.86e-05	0.000375	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—GCLC—chronic obstructive pulmonary disease	2.83e-05	0.000371	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.77e-05	0.000363	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.75e-05	0.00036	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.75e-05	0.000359	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	2.74e-05	0.000358	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.73e-05	0.000357	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.72e-05	0.000357	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	2.7e-05	0.000353	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	2.67e-05	0.00035	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.66e-05	0.000348	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.63e-05	0.000344	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.6e-05	0.000341	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—GCLC—chronic obstructive pulmonary disease	2.6e-05	0.00034	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—CTGF—chronic obstructive pulmonary disease	2.58e-05	0.000338	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.51e-05	0.000328	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.48e-05	0.000325	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.43e-05	0.000318	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.38e-05	0.000312	CbGpPWpGaD
Cyclophosphamide—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	2.38e-05	0.000311	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—CTGF—chronic obstructive pulmonary disease	2.37e-05	0.00031	CbGpPWpGaD
Cyclophosphamide—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	2.28e-05	0.000299	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.18e-05	0.000286	CbGpPWpGaD
Cyclophosphamide—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	2.18e-05	0.000286	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.17e-05	0.000284	CbGpPWpGaD
Cyclophosphamide—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	2.14e-05	0.00028	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.12e-05	0.000277	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—GCLC—chronic obstructive pulmonary disease	2.09e-05	0.000274	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.07e-05	0.000271	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—GCLC—chronic obstructive pulmonary disease	2.05e-05	0.000268	CbGpPWpGaD
Cyclophosphamide—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	2.04e-05	0.000267	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.99e-05	0.00026	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.98e-05	0.000259	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.96e-05	0.000256	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—CTGF—chronic obstructive pulmonary disease	1.91e-05	0.00025	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—CTGF—chronic obstructive pulmonary disease	1.87e-05	0.000245	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.83e-05	0.000239	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.82e-05	0.000238	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.81e-05	0.000237	CbGpPWpGaD
Cyclophosphamide—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	1.8e-05	0.000235	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.8e-05	0.000235	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.79e-05	0.000235	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—GCLC—chronic obstructive pulmonary disease	1.77e-05	0.000232	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Metabolism—ALB—chronic obstructive pulmonary disease	1.77e-05	0.000232	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	1.76e-05	0.000231	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.76e-05	0.000231	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.73e-05	0.000226	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.72e-05	0.000225	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Metabolism—NOS3—chronic obstructive pulmonary disease	1.69e-05	0.000222	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.67e-05	0.000219	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.65e-05	0.000216	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.64e-05	0.000215	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—CTGF—chronic obstructive pulmonary disease	1.62e-05	0.000212	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.6e-05	0.00021	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.59e-05	0.000208	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—GCLC—chronic obstructive pulmonary disease	1.58e-05	0.000207	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.56e-05	0.000205	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.55e-05	0.000202	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.49e-05	0.000195	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.48e-05	0.000193	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.47e-05	0.000193	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.47e-05	0.000192	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.46e-05	0.000191	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	1.46e-05	0.000191	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.45e-05	0.00019	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	1.44e-05	0.000189	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	1.44e-05	0.000189	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.44e-05	0.000188	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.42e-05	0.000185	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.41e-05	0.000185	CbGpPWpGaD
Cyclophosphamide—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.37e-05	0.000179	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.35e-05	0.000177	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.35e-05	0.000176	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.33e-05	0.000174	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	1.33e-05	0.000174	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.32e-05	0.000173	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	1.32e-05	0.000172	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.3e-05	0.00017	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.28e-05	0.000167	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.25e-05	0.000164	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.24e-05	0.000163	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.23e-05	0.000161	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.22e-05	0.00016	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.21e-05	0.000159	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—ALB—chronic obstructive pulmonary disease	1.18e-05	0.000154	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.14e-05	0.00015	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—NOS3—chronic obstructive pulmonary disease	1.13e-05	0.000147	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.11e-05	0.000145	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.09e-05	0.000143	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.08e-05	0.000142	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.08e-05	0.000142	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—ALB—chronic obstructive pulmonary disease	1.08e-05	0.000141	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.07e-05	0.00014	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—NOS3—chronic obstructive pulmonary disease	1.03e-05	0.000135	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.02e-05	0.000134	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.02e-05	0.000134	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.01e-05	0.000132	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.01e-05	0.000132	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.98e-06	0.000131	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.96e-06	0.00013	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.67e-06	0.000127	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.63e-06	0.000126	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	9.52e-06	0.000125	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.44e-06	0.000124	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.38e-06	0.000123	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.3e-06	0.000122	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.89e-06	0.000116	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.82e-06	0.000115	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—ALB—chronic obstructive pulmonary disease	8.7e-06	0.000114	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	8.69e-06	0.000114	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—ALB—chronic obstructive pulmonary disease	8.5e-06	0.000111	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—NOS3—chronic obstructive pulmonary disease	8.32e-06	0.000109	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—NOS3—chronic obstructive pulmonary disease	8.13e-06	0.000106	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8e-06	0.000105	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—ALB—chronic obstructive pulmonary disease	7.36e-06	9.64e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—NOS3—chronic obstructive pulmonary disease	7.04e-06	9.22e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.68e-06	8.74e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.58e-06	8.62e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	6.57e-06	8.6e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	6.42e-06	8.4e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	6.29e-06	8.23e-05	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	6.14e-06	8.03e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.13e-06	8.03e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	6.05e-06	7.91e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	5.99e-06	7.84e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.82e-06	7.61e-05	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	5.78e-06	7.57e-05	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	5.73e-06	7.5e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	3.95e-06	5.17e-05	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	3.78e-06	4.95e-05	CbGpPWpGaD
